The table below shows Guardant Health, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$301.67M
$265.20M
$232.09M
$203.47M
$191.48M
$177.24M
Cost of revenue
$104.92M
$93.59M
$81.20M
$74.72M
$74.49M
$72.42M
Gross profit
-
-
-
-
-
-
R&D
$91.04M
$89.96M
$87.45M
$88.52M
$87.31M
$83.10M
GH annual revenue (10-K history)
Guardant Health, Inc. reported annual revenue of $982.02M for fiscal year 2025. That is up 32.9% from $739.02M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $25.25M (FY 2016) to $982.02M. Figures come from the company's audited annual reports as filed with the SEC.
